SMMT logo

SMMT
Summit Therapeutics Inc

9,554
Mkt Cap
$15.03B
Volume
3.08M
52W High
$36.91
52W Low
$13.83
PE Ratio
-13.41
SMMT Fundamentals
Price
$19.38
Prev Close
$18.92
Open
$18.40
50D MA
$15.90
Beta
1.68
Avg. Volume
2.58M
EPS (Annual)
-$1.44
P/B
22.81
Rev/Employee
$0.00
$12,384.44
Loading...
Loading...
News
all
press releases
Assenagon Asset Management S.A. Invests $1.04 Million in Summit Therapeutics PLC $SMMT
Assenagon Asset Management S.A. purchased a new stake in Summit Therapeutics PLC (NASDAQ:SMMT - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Why Is Ironwood (IRWD) Down 13.9% Since Last Earnings Report?
Ironwood (IRWD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·8d ago
News Placeholder
Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026
Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit, we, or the Company) today announced that data for its novel, potential first-in-class investigational bispecific antibody, ivonescimab, will be...
Business Wire·8d ago
News Placeholder
Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now
Key PointsSummit Therapeutics shares could drop later this year if it doesn't earn approval for its leading candidate...
Nasdaq News: Markets·10d ago
News Placeholder
Summit Therapeutics (NASDAQ:SMMT) Trading 12.1% Higher - Here's What Happened
Summit Therapeutics (NASDAQ:SMMT) Stock Price Up 12.1% - Still a Buy...
MarketBeat·10d ago
News Placeholder
347,241 Shares in Summit Therapeutics PLC $SMMT Acquired by Tudor Investment Corp ET AL
Tudor Investment Corp ET AL acquired a new stake in Summit Therapeutics PLC (NASDAQ:SMMT - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 347,241 shares of the company's stock, valued a...
MarketBeat·11d ago
News Placeholder
Summit Therapeutics (NASDAQ:SMMT) Rating Lowered to "Hold" at Jefferies Financial Group
Jefferies Financial Group downgraded shares of Summit Therapeutics from a "buy" rating to a "hold" rating and set a $15.00 target price for the company. in a research note on Monday...
MarketBeat·19d ago
News Placeholder
Summit Therapeutics (NASDAQ:SMMT) Trading 6.5% Higher - Time to Buy?
Summit Therapeutics (NASDAQ:SMMT) Shares Up 6.5% - Still a Buy...
MarketBeat·22d ago
News Placeholder
WINTON GROUP Ltd Makes New Investment in Summit Therapeutics PLC $SMMT
WINTON GROUP Ltd acquired a new stake in Summit Therapeutics PLC (NASDAQ:SMMT - Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund acquired...
MarketBeat·23d ago
News Placeholder
Summit Therapeutics (NASDAQ:SMMT) Upgraded by Zacks Research to Hold Rating
Zacks Research raised shares of Summit Therapeutics from a "strong sell" rating to a "hold" rating in a report on Thursday...
MarketBeat·28d ago
<
1
2
...
>

Latest SMMT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.